Prince Gold

KRG Korean Red Ginseng

F
N+ Score46
Herbal & BotanicalServing: 1 Capsule(s)Type: Botanical

Prince Gold KRG Korean Red Ginseng is a single-ingredient botanical supplement, providing 518mg of Korea Red Ginseng per capsule. Korean Red Ginseng is widely studied for its adaptogenic properties and potential to support energy, cognitive function, and immune health. While 518mg is a common dosage, research suggests that effective clinical doses for specific outcomes often range from 1,000mg to 3,000mg daily, indicating that this product's dosage may be underdosed for some intended benefits. With only one ingredient, the product offers complete label transparency. It received an N+ Score of 46, earning an 'F' grade, placing it in the below-average tier, primarily due to the potentially insufficient dosage relative to established clinical research. This product may be suitable for individuals seeking a foundational or lower-dose ginseng supplement, though higher doses might be more effective for specific research-backed effects.

About This Product

KRG Korean Red Ginseng by Prince Gold is a herbal & botanical supplement containing 1 active ingredients. It has earned an N+ Score of 46/100 (Grade F).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness0/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity42/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed

Weaknesses

  • −Missing several expected ingredients for its category

Ingredient Analysis (1 ingredients)

IngredientAmountDose Adequacy
Korea Red Ginseng518.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.